BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6136997)

  • 1. Relationships between plasma levels and psychological effects of benzodiazepines.
    Ziegler G; Ludwig L; Klotz U
    Pharmacopsychiatria; 1983 May; 16(3):71-6. PubMed ID: 6136997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of tranquilizers on the critical flicker fusion frequency in the visual analyzer].
    Ben'kovich BI; Marshak OV
    Fiziol Cheloveka; 1984; 10(6):999-1004. PubMed ID: 6151932
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lormetazepam.
    Kurowski M; Ott H; Herrmann WM
    Pharmacopsychiatria; 1982 May; 15(3):77-83. PubMed ID: 6124982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
    Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
    Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and the sedative effect of midazolam.
    Kanto J; Allonen H
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):460-3. PubMed ID: 6138314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of betel nut on human performance.
    Frewer LJ
    P N G Med J; 1990 Jun; 33(2):143-5. PubMed ID: 2238827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of alcohol and other drugs on psychomotor performance and cognitive function.
    Hindmarch I; Kerr JS; Sherwood N
    Alcohol Alcohol; 1991; 26(1):71-9. PubMed ID: 1854375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation between the clinical effect and the pharmacokinetics of midazolam following i.m. and i.v. administration/2nd comm.: Pharmacokinetical aspects (author's transl)].
    Crevoisier C; Eckert M; Heizmann P; Thurneysen DJ; Ziegler WH
    Arzneimittelforschung; 1981; 31(12a):2211-5. PubMed ID: 6120700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pharmacodynamic properties of psychotropic drugs: quanitative EEG, psychometric and blood level investigations in normals and patients.
    Saletu B; Grünberger J
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):45-58. PubMed ID: 419165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of phenazepam on psychophysiological reactions].
    Morozov IS; Rubtsov AT; Braga VV
    Farmakol Toksikol; 1980; 43(1):33-6. PubMed ID: 6103818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of computerized psychomotor testing in determining CNS effects of drugs.
    Berchou R; Block RI
    Percept Mot Skills; 1983 Dec; 57(3 Pt 1):691-700. PubMed ID: 6664751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 150 mg fluconazole does not substantially increase the effects of 10 mg midazolam or the plasma midazolam concentrations in healthy subjects.
    Vanakoski J; Mattila MJ; Vainio P; Idänpään-Heikkilä JJ; Törnwall M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):518-23. PubMed ID: 8520811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pharmacokinetics of midazolam, flunitrazepam and diazepam (author's transl)].
    Lauven PM; Stoeckel H; Schwilden H; Schüttler J
    Anasth Intensivther Notfallmed; 1981 Jun; 16(3):135-42. PubMed ID: 6114680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midazolam: effects on psychomotor performance and subjective aspects of sleep and sedation in normal volunteers.
    Gudgeon AC; Hindmarch I
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):121S-126S. PubMed ID: 6138064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam.
    Chernik DA; Gillings D; Laine H; Hendler J; Silver JM; Davidson AB; Schwam EM; Siegel JL
    J Clin Psychopharmacol; 1990 Aug; 10(4):244-51. PubMed ID: 2286697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam.
    Schaffler K; Kauert G; Wauschkuhn CH; Klausnitzer W
    Arzneimittelforschung; 1989 Feb; 39(2):276-83. PubMed ID: 2567171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of triazolam and nitrazepam on sleep quality, morning vigilance and psychomotor performance.
    Hindmarch I; Clyde CA
    Arzneimittelforschung; 1980; 30(7):1163-6. PubMed ID: 6106500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a sub-chronic administration of three dose levels of a 1,5-benzodiazepine derivative, clobazam, on subjective assessments of sleep and aspects of psychomotor performance the morning following night time medication.
    Hindmarch I; Parrott AC
    Arzneimittelforschung; 1978; 28(11):2169-72. PubMed ID: 40568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.
    Mandema JW; Sansom LN; Dios-Vièitez MC; Hollander-Jansen M; Danhof M
    J Pharmacol Exp Ther; 1991 Apr; 257(1):472-8. PubMed ID: 1850477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal midazolam plasma concentration profile and its effect on anxiety associated with dental procedures.
    Burstein AH; Modica R; Hatton M; Gengo FM
    Anesth Prog; 1996; 43(2):52-7. PubMed ID: 10323126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.